TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
OncoSil Medical Ltd ( (AU:OSL) ) has provided an announcement.
OncoSil Medical Ltd has announced the issuance of new unquoted equity securities, specifically options set to expire in 2028 and 2030, with an exercise price of $1.80. This move is likely to impact the company’s financial structure and could influence its market positioning by potentially increasing capital resources, thereby supporting its ongoing operations and strategic initiatives.
The most recent analyst rating on (AU:OSL) stock is a Sell with a A$1.00 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on the development and commercialization of innovative medical devices for the treatment of cancer. The company is primarily known for its products that target pancreatic and liver cancers, aiming to improve patient outcomes through advanced treatment options.
Average Trading Volume: 26,084
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$20.15M
For detailed information about OSL stock, go to TipRanks’ Stock Analysis page.